<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78294</article-id><article-id pub-id-type="doi">10.7554/eLife.78294</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-271890"><name><surname>Astorga-Gamaza</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271891"><name><surname>Grau-Expósito</surname><given-names>Judith</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271892"><name><surname>Burgos</surname><given-names>Joaquín</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271893"><name><surname>Navarro</surname><given-names>Jordi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7187-0367</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271894"><name><surname>Curran</surname><given-names>Adrià</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271895"><name><surname>Planas</surname><given-names>Bibiana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271896"><name><surname>Suanzes</surname><given-names>Paula</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6871-0098</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271897"><name><surname>Falcó</surname><given-names>Vicenç</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271898"><name><surname>Genescà</surname><given-names>Meritxell</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-221354"><name><surname>Buzon</surname><given-names>Maria</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4427-9413</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Infectious Disease Department</institution>, <institution>Vall d'Hebron Research Institute (VHIR)</institution>, <addr-line><named-content content-type="city">Barcelona</named-content></addr-line>, <country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-90350"><name><surname>Overbaugh</surname><given-names>Julie M</given-names></name><role>Reviewing editor</role><aff><institution>Fred Hutchinson Cancer Research Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>mariajose.buzon@vhir.org</email> (MB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>05</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78294</elocation-id><history><date date-type="received"><day>01</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>23</day><month>05</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Astorga-Gamaza et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Astorga-Gamaza et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78294-v1.pdf"/><abstract><p>HIV establishes a persistent infection in heterogeneous cell reservoirs, which can be maintained by different mechanisms including cellular proliferation, and represent the main obstacle to curing the infection. The expression of the Fcγ receptor CD32 has been identified as a marker of the active cell reservoirs in people on antiretroviral therapy, but if its expression has any role in conferring advantage for viral persistence is unknown. Here, we report that HIV-infected cells expressing CD32 have reduced susceptibility to natural killer (NK) antibody-dependent cell cytotoxicity (ADCC) by a mechanism compatible with the suboptimal binding of HIV-specific antibodies. Infected CD32 cells have increased proliferative capacity in the presence of immune complexes, and are more resistant to strategies directed to potentiate NK function. Remarkably, reactivation of the latent reservoir from antiretroviral-treated people living with HIV increases the pool of infected CD32 cells, which are largely resistant to the ADCC immune mechanism. Thus, we report the existence of reservoir cells that evade part of the NK immune response through the expression of CD32.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>SAF2015-67334-R</award-id><principal-award-recipient><name><surname>Buzon</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>RTI2018-101082-B</award-id><principal-award-recipient><name><surname>Buzon</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Fundació La Marató TV3</institution></institution-wrap></funding-source><award-id>201805-10FMTV3</award-id><principal-award-recipient><name><surname>Buzon</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Fundació La Marató TV3</institution></institution-wrap></funding-source><award-id>201814-10FMTV3</award-id><principal-award-recipient><name><surname>Genescà</surname><given-names>Meritxell</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Spanish Health Institute Carlos III</institution></institution-wrap></funding-source><award-id>CP17/00179</award-id><principal-award-recipient><name><surname>Buzon</surname><given-names>Maria</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017642</institution-id><institution>Spanish National Plan for Scientific and Technical Research and Innovation</institution></institution-wrap></funding-source><award-id>BES-2016-076382</award-id><principal-award-recipient><name><surname>Astorga-Gamaza</surname><given-names>Antonio</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study involves human samples. PBMCs from PLWH were obtained from the HIV unit of the Hospital Universitari Vall d'Hebron in Barcelona, Spain. Study protocols were approved by the corresponding Ethical Committees (Institutional Review Board numbers PR(AG)270/2015 and PR(AG)39/2016). PBMCs from healthy donors were obtained from the Blood and Tissue Bank, Barcelona, Spain. All subjects recruited to this study were adults who provided written informed consent. Samples were completely anonymous and untraceable and were prospectively collected and cryopreserved in the Biobank (register number C.0003590).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The authors declare that the data supporting the findings of this study are available within the paper and its supplementary information files. Source data are provided with this paper.</p></sec><supplementary-material><ext-link xlink:href="elife-78294-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>